This inventor holds 1 USPTO granted patent. Top assignees: Kochi University, Sbi Pharmaceuticals Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 50 
1 out of 41 Years Active: 2017
Title: Innovations in Cancer Detection by Yoshihiko Hirao
Introduction
Yoshihiko Hirao is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of urothelial cancer. His innovative approach aims to simplify the detection process while enhancing accuracy.
Latest Patents
Hirao holds a patent for a method for detecting urothelial cancer. This method involves administering 5-aminolevulinic acid (ALA) or its derivatives to a test subject. Following this, urine is collected from the subject, and the presence or amount of fluorescence in the urine is detected. This technique provides a straightforward and highly accurate means of identifying urothelial cancer.
Career Highlights
Throughout his career, Yoshihiko Hirao has worked with various organizations, including Sbi Pharmaceuticals Co., Ltd. and Kochi University. His work in these institutions has allowed him to develop and refine his innovative cancer detection methods.
Collaborations
Hirao has collaborated with notable colleagues such as Keiji Inoue and Taro Shuin. Their combined expertise has contributed to advancements in medical diagnostics and cancer detection methodologies.
Conclusion
Yoshihiko Hirao's contributions to cancer detection represent a significant advancement in medical technology. His innovative methods have the potential to improve patient outcomes through early and accurate diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile